{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:58:54Z","timestamp":1789037934717,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T00:00:00Z","timestamp":1524009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The loss of p300\/CBP-associated protein (PCAF) expression is associated with poor clinical outcome in gastric cancer, and a potential bio-marker for invasive and aggressive tumors. However, the mechanism linking loss of PCAF to the onset of gastric cancer has not been identified. Given that PCAF and its binding partner transcriptional adaptor protein 3 (ADA3) were recently shown to regulate the intrinsic (mitochondrial) pathway to apoptosis via epigenetic regulation of phosphofurin acidic cluster sorting proteins 1 and 2 (PACS1, PACS2), we analyzed PCAF, ADA3, and PACS1\/2 expression in 99 patient-matched surgical samples ranging from normal gastric mucosa, through pre-malignant chronic gastritis and intestinal metaplasia to stage I\u2013III invasive cancers. PCAF mRNA levels were not reduced in either pre-malignant state but were significantly down-regulated in all stages of gastric cancer, commencing at AJCC stage I (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05), thus linking reduced PCAF expression with early malignant change. Furthermore, patients with combined reduction of PCAF and PACS1 had significantly poorer overall survival (<jats:italic>p<\/jats:italic>\u2009=\u20090.0257), confirmed in an independent dataset of 359 patients (<jats:italic>p<\/jats:italic>\u2009=\u20095.8\u2009\u00d7\u200910e-6). At the protein level, PCAF, ADA3, and PACS1 expression were all significantly down-regulated in intestinal-type gastric cancer, and correlated with reduced progression free survival. We conclude that a pro-apoptotic mechanism centered on the intrinsic (mitochondrial) pathway and regulated by PCAF\/ADA3 can influence the progression from premalignant to malignant change, and thus act as a tumor suppression mechanism in gastric cancer.<\/jats:p>","DOI":"10.1038\/s41419-018-0470-8","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T10:50:45Z","timestamp":1524048645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Down-regulation of a pro-apoptotic pathway regulated by PCAF\/ADA3 in early stage gastric cancer"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-9611","authenticated-orcid":false,"given":"Daniella","family":"Brasacchio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita A.","family":"Busuttil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricky W.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Boussioutas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,18]]},"reference":[{"key":"470_CR1","first-page":"M37","volume":"1470","author":"RL Schiltz","year":"2000","unstructured":"Schiltz, R. L. & Nakatani, Y. The PCAF acetylase complex as a potential tumor suppressor. Biochim. Biophys. Acta 1470, M37\u2013M53 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"470_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1128\/MCB.19.2.1202","volume":"19","author":"L Liu","year":"1999","unstructured":"Liu, L. et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell Biol. 19, 1202\u20131209 (1999).","journal-title":"Mol. Cell Biol."},{"key":"470_CR3","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1062374","volume":"293","author":"L Chen","year":"2001","unstructured":"Chen, L., Fischle, W., Verdin, E. & Greene, W. C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293, 1653\u20131657 (2001).","journal-title":"Science"},{"key":"470_CR4","doi-asserted-by":"publisher","first-page":"8404","DOI":"10.1158\/0008-5472.CAN-06-0683","volume":"66","author":"JS Sunde","year":"2006","unstructured":"Sunde, J. S. et al. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. Cancer Res. 66, 8404\u20138412 (2006).","journal-title":"Cancer Res."},{"key":"470_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.devcel.2012.01.009","volume":"22","author":"E Choi","year":"2012","unstructured":"Choi, E. et al. BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylation. Dev. Cell 22, 295\u2013308 (2012).","journal-title":"Dev. Cell"},{"key":"470_CR6","first-page":"4287","volume":"25","author":"R Giannini","year":"2005","unstructured":"Giannini, R. & Cavallini, A. Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma. Anticancer Res. 25, 4287\u20134292 (2005).","journal-title":"Anticancer Res."},{"key":"470_CR7","doi-asserted-by":"publisher","first-page":"10047","DOI":"10.1074\/jbc.M408680200","volume":"280","author":"W Huang","year":"2005","unstructured":"Huang, W. et al. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF\/p300 to a Sp1.NF-Y complex. J. Biol. Chem. 280, 10047\u201310054 (2005).","journal-title":"J. Biol. Chem."},{"key":"470_CR8","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1038\/onc.2009.137","volume":"28","author":"C Zhu","year":"2009","unstructured":"Zhu, C. et al. Characterization of tumor suppressive function of P300\/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma. Oncogene 28, 2821\u20132828 (2009).","journal-title":"Oncogene"},{"key":"470_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4161\/cbt.9.4.10748","volume":"9","author":"MZ Ying","year":"2009","unstructured":"Ying, M. Z. et al. The p300\/CBP associated factor: is frequently downregulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcome. Cancer Biol. Ther. 9, 312\u2013320 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"470_CR10","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/ijc.27711","volume":"132","author":"F Bray","year":"2013","unstructured":"Bray, F., Ren, J. S., Masuyer, E. & Ferlay, J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int. J. Cancer J. Int. Cancer 132, 1133\u20131145 (2013).","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"470_CR11","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer J. Int. Cancer 136, E359\u2013E386 (2015).","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"470_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Et. Microbiol. Scand. 64, 31\u201349 (1965).","journal-title":"Acta Pathol. Et. Microbiol. Scand."},{"key":"470_CR13","first-page":"3554","volume":"48","author":"P Correa","year":"1988","unstructured":"Correa, P. A human model of gastric carcinogenesis. Cancer Res. 48, 3554\u20133560 (1988).","journal-title":"Cancer Res."},{"key":"470_CR14","doi-asserted-by":"publisher","first-page":"12016","DOI":"10.18632\/oncotarget.2434","volume":"5","author":"RA Busuttil","year":"2014","unstructured":"Busuttil, R. A. et al. Role of p53 in the progression of gastric cancer. Oncotarget 5, 12016\u201312026 (2014).","journal-title":"Oncotarget"},{"key":"470_CR15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/cdd.2013.203","volume":"21","author":"D Brasacchio","year":"2014","unstructured":"Brasacchio, D. et al. A functional genomics screen identifies PCAF and ADA3 as regulators of human granzyme B-mediated apoptosis and Bid cleavage. Cell Death Differ. 21, 748\u2013760 (2014).","journal-title":"Cell Death Differ."},{"key":"470_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s10549-012-2363-3","volume":"137","author":"S Mirza","year":"2013","unstructured":"Mirza, S. et al. Cytoplasmic localization of alteration\/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients. Breast Cancer Res Treat. 137, 721\u2013731 (2013).","journal-title":"Breast Cancer Res Treat."},{"key":"470_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/cdd.2016.119","volume":"24","author":"D Brasacchio","year":"2017","unstructured":"Brasacchio, D. et al. Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX\/BAK oligomerization. Cell Death Differ. 24, 961\u2013970 (2017).","journal-title":"Cell Death Differ."},{"key":"470_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.emboj.7600559","volume":"24","author":"T Simmen","year":"2005","unstructured":"Simmen, T. et al. PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis. EMBO J. 24, 717\u2013729 (2005).","journal-title":"EMBO J."},{"key":"470_CR19","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1084\/jem.192.10.1403","volume":"192","author":"VR Sutton","year":"2000","unstructured":"Sutton, V. R. et al. Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J. Exp. Med. 192, 1403\u20131414 (2000).","journal-title":"J. Exp. Med."},{"key":"470_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1074-7613(03)00050-5","volume":"18","author":"VR Sutton","year":"2003","unstructured":"Sutton, V. R., Wowk, M. E., Cancilla, M. & Trapani, J. A. Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity 18, 319\u2013329 (2003).","journal-title":"Immunity"},{"key":"470_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik, I., Whisstock, J. C. & Trapani, J. A. Perforin and granzymes: function, dysfunction and human pathology. Nat. Rev. Immunol. 15, 388\u2013400 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"470_CR22","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1158\/1078-0432.CCR-13-3049","volume":"20","author":"RA Busuttil","year":"2014","unstructured":"Busuttil, R. A. et al. A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 20, 2761\u20132772 (2014).","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"470_CR23","doi-asserted-by":"publisher","first-page":"49322","DOI":"10.18632\/oncotarget.10337","volume":"7","author":"AM Szasz","year":"2016","unstructured":"Szasz, A. M. et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget 7, 49322\u201349333 (2016).","journal-title":"Oncotarget"},{"key":"470_CR24","first-page":"74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA: Cancer J. Clin. 55, 74\u2013108 (2005).","journal-title":"CA: Cancer J. Clin."},{"key":"470_CR25","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1007\/s13277-014-1841-0","volume":"35","author":"F Wisnieski","year":"2014","unstructured":"Wisnieski, F. et al. Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A. Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med. 35, 6373\u20136381 (2014).","journal-title":"Tumour Biol.: J. Int. Soc. Oncodev. Biol. Med."},{"key":"470_CR26","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1101\/gad.184705.111","volume":"26","author":"G Spedale","year":"2012","unstructured":"Spedale, G., Timmers, H. T. & Pijnappel, W. W. ATAC-king the complexity of SAGA during evolution. Genes Dev. 26, 527\u2013541 (2012).","journal-title":"Genes Dev."},{"key":"470_CR27","doi-asserted-by":"publisher","first-page":"6234","DOI":"10.1093\/emboj\/cdg596","volume":"22","author":"GK Scott","year":"2003","unstructured":"Scott, G. K. et al. The phosphorylation state of an autoregulatory domain controls PACS-1-directed protein traffic. EMBO J. 22, 6234\u20136244 (2003).","journal-title":"EMBO J."},{"key":"470_CR28","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1038\/sj.onc.1205698","volume":"21","author":"ES Srivatsan","year":"2002","unstructured":"Srivatsan, E. S. et al. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Oncogene 21, 5631\u20135642 (2002).","journal-title":"Oncogene"},{"key":"470_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081016","volume":"421","author":"RT Youker","year":"2009","unstructured":"Youker, R. T., Shinde, U., Day, R. & Thomas, G. At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis. Biochem. J. 421, 1\u201315 (2009).","journal-title":"Biochem. J."},{"key":"470_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1172\/JCI69738","volume":"124","author":"AC West","year":"2014","unstructured":"West, A. C. & Johnstone, R. W. New and emerging HDAC inhibitors for cancer treatment. J. Clin. Investig. 124, 30\u201339 (2014).","journal-title":"J. Clin. Investig."},{"key":"470_CR31","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1016\/j.canep.2012.05.011","volume":"36","author":"A Akil","year":"2012","unstructured":"Akil, A. et al. Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma. Cancer Epidemiol. 36, e300\u2013e305 (2012).","journal-title":"Cancer Epidemiol."},{"key":"470_CR32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/ijc.23577","volume":"123","author":"YR Qin","year":"2008","unstructured":"Qin, Y. R. et al. Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. Int. J. Cancer J. Int. Cancer 123, 826\u2013830 (2008).","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"470_CR33","first-page":"2569","volume":"63","author":"A Boussioutas","year":"2003","unstructured":"Boussioutas, A. et al. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 63, 2569\u20132577 (2003).","journal-title":"Cancer Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0470-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:53:02Z","timestamp":1671537182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0470-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,18]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["470"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0470-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,18]]},"assertion":[{"value":"6 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"442"}}